Interestingly, DZNep treatment induces apoptosis of chondrosarcoma cell lines whereas it has a weak effect on normal chondrocyte, and reduces cell migration, suggesting that targeting EZH2, for instance using DZNep, may be an innovative therapeutic strategy to treat chondrosarcomas. This evidence concerns the gene EZH2 and chondrosarcoma.